Mondobiotech


Mondobiotech is a Swiss-based biotechnology company focused on developing human peptides as medicaments for patients affected by rare diseases.

History

Mondobiotech was founded in 2000 by Fabio Cavalli and Dorian Bevec.[1] In March 2012, Pharma Times'in exclusive negotiations with Pierrel Research, the contact research division of the Italian company Pierrel.[2]

Research and development

Mondobiotech creates drugs for rare diseases.

Achievements
  • Winner of the Swiss Life Sciences Prize 2005.
  • Selected Technology Pioneer 2008 by The World Economic Forum.

Notes and references
  1. "Archived copy". Archived from the original on 2012-07-20. Retrieved 2012-02-29.CS1 maint: archived copy as title (link)
  2. Mansell, Peter (6 March 2012). "Pierrel in negotiations for mondoBIOTECH merger". Pharma Times. Retrieved 9 March 2015.

See also


This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.